CJC-1295 vs GHRP-2 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
CJC-1295 is a synthetic GHRH analog with a Drug Affinity Complex (DAC) that binds circulating albumin, extending half-life from 7 minutes to approximately 6-8 days. Enables once-weekly dosing with sustained GH elevation. Phase I/II clinical research status. WADA prohibited under ...
Calculate CJC-1295 dose →GHRP-2 (Pralmorelin) is a synthetic hexapeptide growth hormone releasing peptide and one of the most potent first-generation GHRPs. It stimulates pituitary GH secretion via the ghrelin receptor (GHSR-1a) with greater potency than GHRP-6, while producing less appetite stimulation....
Calculate GHRP-2 dose →| Parameter | CJC-1295 | GHRP-2 |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| Research | Extensively Studied | Extensively Studied |
| Half-Life | ~6–8 days (with DAC) | ~30–60 min |
| Typical Dose | 1–2 mg | 100–300 µg |
| Frequency | Once weekly or twice weekly | 1–3× daily |
| Route | Subcutaneous | Subcutaneous |
| FDA Status | Not Approved | Not Approved (US) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.